Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongbin Lv

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Eye (London, England)|January 30, 2026
Schwartz-Matsuo syndromeGuangwei Yu, Yongbin Lv, Donglin Wang
Oncology Letters|May 10, 2018
Imaging performance and clinical value of contrast-enhanced ultrasonography and computed tomography in the diagnosis of liver cancerBolin Sun, Yongbin Lv, Dong Xing, et al.
Journal of Computer Assisted Tomography|April 30, 2020
Diagnostic Value of Quantitative Gray-Scale Analysis of Contrast-Enhanced Spectral Mammography for Benign and Malignant Breast LesionsYongbin Lv, Xiaoxiao Chi, Bolin Sun, et al.
Medicine|December 22, 2020
Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary studyLiangliang Yu, Yongtao Wang, Dong Xing, et al.
Scientific Reports|March 16, 2021
Quantitative analysis of contrast enhanced spectral mammography grey value for early prediction of pathological response of breast cancer to neoadjuvant chemotherapyDong Xing, Ning Mao, Jianjun Dong, et al.
Academic Radiology|April 19, 2024
Develop and Validate a Nomogram Combining Contrast-Enhanced Spectral Mammography Deep Learning with Clinical-Pathological Features to Predict Neoadjuvant Chemotherapy Response in Patients with ER-Positive/HER2-Negative Breast CancerDong Xing, Yongbin Lv, Bolin Sun, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 5, 2017
Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) PatientsYongbin Lv, Yinghua Pan, Changxia Dong, et al.
Medicine|September 14, 2020
Diagnostic value of the enhancement intensity and enhancement pattern of CESM to benign and malignant breast lesionsXiaoxiao Chi, Lei Zhang, Dong Xing, et al.
International Journal of Clinical and Experimental Medicine|February 18, 2016
Imaging study on the optic canal using sixty four-slice spiral computed tomographyPeng-Fei Jiang, Xiu-Yu Dai, Yongbin Lv, et al.
Journal of Biosciences|December 15, 2016
Long non-coding RNA <i>HOTAIR</i> regulates proliferation and invasion via activating Notch signalling pathway in retinoblastomaChangxia Dong, Shaoyi Liu, Yongbin Lv, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Eye (London, England)|January 30, 2026
Schwartz-Matsuo syndromeGuangwei Yu, Yongbin Lv, Donglin Wang
Oncology Letters|May 10, 2018
Imaging performance and clinical value of contrast-enhanced ultrasonography and computed tomography in the diagnosis of liver cancerBolin Sun, Yongbin Lv, Dong Xing, et al.
Journal of Computer Assisted Tomography|April 30, 2020
Diagnostic Value of Quantitative Gray-Scale Analysis of Contrast-Enhanced Spectral Mammography for Benign and Malignant Breast LesionsYongbin Lv, Xiaoxiao Chi, Bolin Sun, et al.
Medicine|December 22, 2020
Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary studyLiangliang Yu, Yongtao Wang, Dong Xing, et al.
Scientific Reports|March 16, 2021
Quantitative analysis of contrast enhanced spectral mammography grey value for early prediction of pathological response of breast cancer to neoadjuvant chemotherapyDong Xing, Ning Mao, Jianjun Dong, et al.
Academic Radiology|April 19, 2024
Develop and Validate a Nomogram Combining Contrast-Enhanced Spectral Mammography Deep Learning with Clinical-Pathological Features to Predict Neoadjuvant Chemotherapy Response in Patients with ER-Positive/HER2-Negative Breast CancerDong Xing, Yongbin Lv, Bolin Sun, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 5, 2017
Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) PatientsYongbin Lv, Yinghua Pan, Changxia Dong, et al.
Medicine|September 14, 2020
Diagnostic value of the enhancement intensity and enhancement pattern of CESM to benign and malignant breast lesionsXiaoxiao Chi, Lei Zhang, Dong Xing, et al.
International Journal of Clinical and Experimental Medicine|February 18, 2016
Imaging study on the optic canal using sixty four-slice spiral computed tomographyPeng-Fei Jiang, Xiu-Yu Dai, Yongbin Lv, et al.
Journal of Biosciences|December 15, 2016
Long non-coding RNA <i>HOTAIR</i> regulates proliferation and invasion via activating Notch signalling pathway in retinoblastomaChangxia Dong, Shaoyi Liu, Yongbin Lv, et al.
Pageof 2